Thiotepa
Active substance: thiotepa
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · THIOTEPA 100 mg/1
United StatesActive
Marketing holder: Dr.Reddy's Laboratories Inc.,
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- THIOTEPA · 100 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-b42a-7aff-b234-38aa8df54ff1,01a1208c-b440-7365-8b52-f5bce5fc3d24,01a1208c-c8e2-7ea6-8aae-3c07c8d23379,01a1208d-1307-7cd2-b346-e32af6e2eb6c,01a1208d-78e4-70d6-9ffa-9b650f7f1b7b;count=17 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 43598-171
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Sources
- product · openFDA NDC · 43598-171 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43598-171 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43598-171 · Verified 2026-10-09 · open in source